Rates of cardiovascular and renal disease in Australian Aboriginal communities are high, but we do not know the contribution of inflammation to these diseases in this setting. In the present study, we sought to examine the distribution of C-reactive protein (CRP) and other markers of inflammation and their relationships with cardiovascular risk markers and renal disease in a remote Australian Aboriginal community. The study included 237 adults (58 % of the adult population) in a remote Aboriginal community in the Northern Territory of Australia. Main outcome measures were CRP, fibrinogen and IgG concentrations, blood pressure (BP), presence of diabetes, lipids, albuminuria, seropositivity to three common micro-organisms, as well as carotid intima-media thickness (IMT). Serum concentrations of CRP [7 (5-13) mg/l; median (inter-quartile range)] were markedly increased and were significantly correlated with fibrinogen and IgG concentrations and inversely correlated with serum albumin concentration. Higher CRP concentrations were associated with IgG seropositivity to Helicobacter pylori and Chlamydia pneumoniae and higher IgG titre for cytomegalovirus. Higher CRP concentrations were associated with the following: the 45-54-year age group, female subjects, the presence of skin sores, higher body mass index, waist circumference, BP, glycated haemoglobin and greater albuminuria. CRP concentrations increased with the number of cardiovascular risk factors, carotid IMT and albuminuria independently of other risk factors. These CRP concentrations were markedly higher than described in other community settings and are probably related, in a large part, to chronic and repeated infections. Their association with markers of cardiovascular risk and renal disease are compatible with the high rates of cardiovascular and renal disease in this community, and provide more evidence of strong links between these conditions, through a shared background of infection/inflammation. This suggests that a strong focus on prevention and management of infections will be important in reducing these conditions, in addition to interventions directed at more traditional risk factors.
INTRODUCTION
Rates of cardiovascular morbidity and mortality among Australian Aborigines are high, particularly between 25 and 55 years of age, where age-specific rates are 5-10 times those of non-indigenous Australians [1] . Rates of end-stage renal disease are also extremely high, particularly among those living in the Northern Territory and other remote areas [2] . In one Aboriginal community, albuminuria has been shown to be predictive of subsequent end-stage renal disease [3] and death [4] . High rates of some traditional cardiovascular risk factors such as smoking and diabetes have been described in Aboriginal communities [5] [6] [7] , whereas others, such as cholesterol levels, are not excessively high [8] . Extremely high rates of infection are characteristic of this environment, affecting most organ systems, with chronic ear infections, periodontal disease and pulmonary and gastrointestinal infections being especially common. These diseases occur against a background of poor living conditions, with widespread overcrowding, substandard housing, poverty, unemployment and poor nutrition [9] .
A number of 'non-traditional' markers of cardiovascular risk have been described in recent years [10] [11] [12] [13] [14] [15] [16] [17] [18] . Several markers of inflammation have been shown to predict an increased risk of atherosclerosis and cardiovascular mortality in urbanized settings. Increased C-reactive protein (CRP) concentrations, in particular, have been shown to be a risk factor for cardiac mortality [10] [11] [12] [13] . Other markers of inflammation, such as serum amyloid P protein, interleukin-6 and white cell count [14] , and haemostatic factors, such as fibrinogen, von-Willebrand's factor and plasminogen activator inhibitor-1 (PAI-1), have also been associated with vascular disease in different populations [15] [16] [17] [18] . The distribution of these markers and the role they play in cardiovascular and renal disease in Aboriginal Australians in remote communities is unclear.
The aim of the present study was to describe the distribution of CRP, a marker of inflammation, and its relationships with the traditional cardiovascular risk factors in an Aboriginal community in the remote East Arnhem region of the Northern Territory of Australia. Cardiovascular mortality rates are elevated in this region, with an age-adjusted rate of 700/million per year for Aboriginal males and 540/million per year for females for the period 1986-1995, compared with the Northern Territory non-Aboriginal rates for male and females of 300 and 170/million per year respectively [19] . Rates of renal disease in this community are also high, with widespread albuminuria [20] and age-adjusted rates of end-stage renal disease 15 times the national nonAboriginal rate.
METHODS
Members of the community aged 18 years and older were invited during 1999 and early 2000 to participate in the project by local advertising, word of mouth and personal invitation. After consent was given, a questionnaire was completed, a brief physical examination was performed and blood and urine specimens were obtained. Resting blood pressure (BP) was measured twice at rest (5 min apart) by a single observer using a mercury sphygmomanometer. Weight was measured with an electronic scale, standing height with a wall-mounted stadiometer, and waist and hip circumference with a measuring tape. The skin was examined for active sores. Chest auscultation was performed on all participants, and the presence of pulmonary rhonchi and crepitations noted. A review of the medical chart was also performed, and the prescription of angiotensin-converting-enzyme (ACE)-inhibitors and aspirin noted.
Blood and urine specimens were taken from nonfasting subjects and collected irrespective of the time of day. Blood was drawn into vacuette tubes, and serum was separated within 20 min, then stored at 4
• C until transfer to the pathology laboratory by air within 24 h.
Serum was analysed for electrolytes, urea, creatinine, albumin, IgG, IgM and IgA, total cholesterol and highdensity lipoprotein (HDL)-cholesterol, lipoprotein a [Lp(a)] and triacylglycerols (triglycerides) using standard automated analysers. Serum CRP concentrations were assayed using rate nephelometry (Immage Rate Nephelometer BN2; Beckman Coulter, Fullerton, CA, U.S.A.), with a lower limit of detection of 1 mg/l and a coefficient of variability < 6.5 % for inter-assay precision. The proportion of glycated haemoglobin (HbA 1c ) was analysed on whole venous blood. Fibrinogen concentrations were measured using the Behring BHS coagulation system (Dade-Behring, Deerfield, IL, U.S.A.). Serum IgG for Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus (CMV) was assayed using the relevant kits (Dade-Behring Enzygnost; Dade-Behring, Deerfield, IL, USA). Both C. pneumoniae and H. pylori were reported as positive or negative depending on the presence of specific antibodies. Since all subjects were positive for CMV IgG, we used the actual antibody titre in the statistical analyses. Serum homocysteine concentrations were measured using the Abbott IMx assay (Abbott Laboratories, Abbott Park, IL, U.S.A.).
Low-density lipoprotein (LDL)-cholesterol concentration was calculated using the Friedewald equation [21] providing the serum triacylglycerol concentration was < 4.5 mmol/l. Albumin and creatinine concentrations were analysed in the urine sample and an albumin/ creatinine ratio (ACR) was calculated. This was classified into 'normal' (ACR < 3.4 g/mol), 'microalbuminuria' (ACR 3.4-33.9 g/mol) and 'overt albuminuria' (ACR 34 g/mol) [22] . Glomerular filtration rate (GFR) was estimated using the Modification of Diet in Renal Disease (MDRD) study formula [23] .
For each person, a cardiovascular 'risk factor score' was calculated from the number of 'traditional' cardiovascular risk factors present. These were HbA 1c 6.5 %, HDLcholesterol 0.8 mmol/l, overweight [body mass index (BMI) 25 kg/m 2 ] and hypertension (systolic BP 140 mmHg or diastolic BP 90 mmHg), giving a score ranging from 0-4.
Carotid intima-media thickness (IMT) was used as a surrogate measure of atherosclerotic burden. This was measured in the distal 10 mm of the common carotid artery. On each side, three images were obtained from antero-lateral, lateral and postero-lateral aspects using a Sonos 100CF ultrasound unit with a 7.5 MHz annular array transducer (Hewlett-Packard, Boise, ID, U.S.A.). The images were recorded on super-VHS video tape, and subsequently digitized using a commercial frame-grabber (Zipshot; Arcsoft Corporation, Fremont, CA, U.S.A.). IMT was then measured using a computerized edgedetection program, and a mean obtained for each scan and an overall mean IMT. All scans and measurements were performed by one observer, and the intra-observer coefficient of variation was 7.4 %. We used the upper quartile of IMT ('increased IMT') as a categorical, rather than continuous, dependent variable, as the relationship between carotid IMT and risk of cardiovascular mortality is not linear [24] .
Concentrations of total homocysteine, HDLcholesterol, IgG, fibrinogen and CRP were logarithmically transformed, and HbA 1c proportion and CMV IgG titre were divided into quartiles owing to marked right skews. Means and confidence intervals (CI) for all transformed variables are presented after backtransformation to their original scale. Relationships between independent and dependent variables were inspected visually for linearity, using scatter plots and examination of distribution of residuals. Independent variables were modelled as a series of categories where non-linearity was found. Predictors of CRP and fibrinogen were evaluated in regression analyses, with coefficients presented after exponentiation. The backtransformed coefficient is therefore the multiplicative change (95 % CI) in the dependent variable for a oneunit change in the independent variable. Predictors were included in a multivariate model on the basis of biological interest as cardiovascular risk factors if they had a univariate relationship with CRP in these data at P < 0.20. Factors were then dropped from the multivariate equations if their P values were 0.10 or greater. Correlations among the markers of inflammation were also examined using Pearson's correlation coefficient (r). A P value of 0.05 was used for statistical significance. Given the hypothesis-generating role of the study, formal adjustment for multiple comparisons was not performed. 
RESULTS
A total of 237 people (133 female) were recruited from the community, which is approx. 58 % of the eligible community population according to the 1996 Australian Census of Population and Housing. The study population has been partially described previously [20] , and is summarized in Table 1 . Rates of tobacco smoking, increased waist circumference and waist/hip ratio, diabetes and albuminuria were high, but rates of hypertension and mean values of BMI, hyperlipidaemia and increased homocysteine concentrations were not increased compared with values in Australian nonindigenous populations. [26] Overall, serum CRP concentrations were high, with a range between 1 and 46 mg/l and median of 7 (5-13) mg/l {median [inter-quartile range (IQR)]}. CRP concentrations varied with age and were greatest in the 45-54-year age group (P < 0.001, ANOVA F = 5.8; Figure 1 ). CRP concentrations were associated with most 'traditional' cardiovascular risk factors; they increased progressively across the entire range of HbA 1c (Figure 2 ), and were associated with BP, BMI, waist circumference, waist/hip ratio, urine ACR and (inversely) with HDLcholesterol concentration, in both crude and ageand gender-adjusted analyses. Cigarette smoking was associated with lower CRP concentrations, although this was only of marginal significance once adjusted for age and gender. ACE-inhibitor use was associated with a higher CRP concentration in univariate analyses, but not after adjustment for age and gender. Lp(a) concentrations were low overall, but were not related to CRP concentration.
CRP concentrations were not associated with total homocysteine concentration ( Table 2) .
Seropositivity to C. pneumoniae and H. pylori were common and universal for CMV. C. pneumoniae and H. pylori IgG seropositivity remained significantly associated with CRP in age-and gender-adjusted analyses, but CMV IgG titre was not ( Table 2) .
The presence of pulmonary crepitations and skin sores was associated with an increased CRP concentration. In the age-and gender-adjusted analyses, mean CRP concentrations were higher among those with skin sores and among those seropositive for H. pylori and C. pneumoniae, but not among those in the upper quartile of the CMV IgG titre. CRP concentrations, after adjustment for age and gender, did not differ with reported cough, wheeze or dyspnoea. Serum concentrations of CRP were significantly correlated with concentrations of fibrinogen (r = 0.39, P < 0.001) and total IgG (r = 0.24, P < 0.001), but not with concentrations of IgM or IgA. CRP concentrations were inversely correlated with serum albumin concentration (r = − 0.19, P = 0.005).
CRP concentrations were associated with the proportion of people with 'increased IMT' in both crude and age-adjusted analyses (Table 2 ). This association was not, however, independent of the other cardiovascular risk factors in the multivariate model (adjusted P = 0.1 when added to final model from Table 2 .).
CRP concentrations were directly associated with the risk factor score, increasing by 1.31 (1.18-1.46)-fold per risk factor (P < 0.001; Figure 3 ). Micro-albuminuria and overt albuminuria were also significantly associated with CRP levels, even after adjustment for risk factor score, age and gender, with an increase in CRP by a factor of 1.39 (1.08-1.81)-fold for micro-albuminuria (P = 0.01) and 1.50 (1.04-2.17)-fold for overt albuminuria (P = 0.03).
IgG concentrations were also widely increased [19.4 (16.6-22.5) g/l; value is median (IQR); laboratory reference range upper limit 15 g/l]. Both IgG and fibrinogen concentrations were directly correlated with CRP. They were similarly correlated with measures of body fat, urine ACR and carotid IMT and inversely correlated with HDL-cholesterol and GFR. They were, however, not significantly correlated with the risk factor score after adjustment for age and gender.
An initial multiple regression model examined possible predictors of CRP and included BMI, waist circumference, systolic BP, diastolic BP, skin sores, pulmonary
Table 2 Coefficients of regression of variables against the CRP concentration as the dependent variable
Values are exponentiated coefficients (95 % CI). CRP coefficients were log-transformed for analysis, and coefficients subsequently exponentiated and, therefore, refer to multiplicative change in CRP for each unit change in the independent variable. Per S.D., independent variables have been standardized, so the regression coefficient is the change in the dependent variable for a change in the independent variable of one S.D. (of the independent variable). †Variable log-transformed for analysis. WHR, waist/hip ratio; IU, international units. crepitations, HDL-cholesterol concentration, HbA 1c quartile, albuminuria categories, calculated GFR and the serological markers. Sequentially dropped from the model were terms for cigarette smoking, waist circumference, CMV IgG serology, HbA 1c quartile, diabetes, calculated GFR, BMI, pulmonary crepitations, systolic BP and skin sores. The remaining independent predictors of CRP concentration were age category, male gender, albuminuria categories, HDL-cholesterol concentration, C. pneumoniae and H. pylori serology and diastolic BP (Table 3) .
DISCUSSION
The mean CRP concentrations in the present study are consistent with those recently reported from another [28] . These CRP concentrations are, however, much higher than those in studies in which the relationships between CRP and cardiovascular risk were first described in other settings [29, 30] . Among 28 000 US females in the Women's Health Study, the serum CRP concentration was 1.5 (0.61-3.5) mg/l [median (IQR)] [29] , and the Framingham Heart study reported median (IQR) CRP concentrations of 1.45 (0.34-4.32) mg/l for men and 1.71 (0.28-5.59) mg/l among women [30] . Median concentration in other studies have usually been in the range 0.3-2 mg/l [10, 11, 13, [31] [32] [33] [34] . CRP concentrations comparable with those in our study have also been described in dialysis patients [35] [36] [37] , where they are potentially explained by repeated invasive procedures, more frequent infections and exposures to the dialysis procedure itself, as well as a possible contribution from the uraemic state [38] . The high CRP concentrations seen in our present study are probably multideterminant. They might reflect the effect of atherosclerotic lesions and endothelial inflammation and the proinflammatory effect of adipose tissue [39] [40] [41] . However, the greatly increased burden of infection in this population is also likely to be a major contributor. CRP concentrations were correlated with at least one marker of clinical infection (skin sores), with total IgG levels (a marker of infection/inflammation which has a much longer half life than CRP) and with some serological markers of specific infections. The rates of seropositivity for all the infectious markers were, in turn, much higher than reported for non-indigenous Australians [42, 43] . C. pneumoniae seroprevalence of 58 % was reported from one population-based study [42] (compared with 87 % in the present study), H. pylori seroprevalence of 31 % was observed in a regional Australian centre [43] (compared with 72 % in the present study), and CMV IgG was present in 128 out of 196 (65 %) cadaveric organ donors in Australia in 2000 (L. Excell, personal communication; compared with 100 % in the present study).
The high prevalence of renal impairment in this community raises the question of whether reduced renal function contributes to the high CRP concentrations. Although a renal route of elimination of CRP has not been defined, increased concentrations of CRP have been reported among elderly people with mild renal impairment [44] , pre-dialysis patients with severe renal failure [45] and dialysis patients [35] [36] [37] . However, a comparison of a large U.S. trial group with moderate renal failure with a U.S. general population study did not show any evidence of an increase in CRP associated with impaired renal function in the GFR range 20-55 ml · min −1 · 1.73 m −2 [46] . Thus, although an effect of renal function on CRP concentrations at the levels of renal impairment in our present study appears unlikely, definitive evidence from longitudinal studies examining CRP changes with deteriorating renal function is not available.
In addition to correlations with indicators of infection, CRP concentrations were related to 'traditional' cardiovascular risk factors, including HbA 1c , overweight, BP and with a composite cardiovascular risk score, as well as the structural marker of cardiovascular risk, carotid IMT. CRP was also correlated with renal disease, marked by higher ACRs and lower GFRs; the association of albuminuria with CRP concentration was independent of other cardiovascular risk factors.
The very high levels of CRP are compatible with the greatly elevated rates of cardiovascular and renal disease in this and other Aboriginal communities. These links with both cardiovascular and renal disease provide further evidence of a close association between these conditions [7] through a common background of inflammation and infection. The association of ACE-inhibitor use with higher CRP concentration is likely to reflect prescription of these agents for cardiovascular disease and renal disease which, in turn, are associated with CRP concentration, rather than stimulation of CRP synthesis by ACEinhibitors.
Our present data are consistent with other reports linking CRP with insulin resistance [47, 48] and albuminuria [49] , but the present study extends these associations through ranges of CRP and levels of albuminuria, diabetes and cardiovascular disease that are considerably higher than in previous population studies [10] [11] [12] [13] . Without inferring causation, CRP is thus still a powerful marker of renal and cardiovascular risk where the burden of disease is very high.
The inferences are likely to be generally applicable to other remote Aboriginal communities with similarly increased rates of renal and cardiovascular disease. Further generalization to indigenous groups in other countries may also be appropriate or to other groups exposed to similar environmental influences. Little is known, however, about CRP concentrations in groups with high rates of renal disease, including some American Indian groups and Canadian First Nations people.
These present findings suggest that interventions to control cardiovascular and renal disease need to be expanded beyond the traditional areas of diet, exercise and control of BP and metabolic profiles to include vigorous initiatives to prevent and control infections. Whether reduction of the widespread inflammation observed in the present study will causally influence cardiovascular or renal disease rates is unknown, but the very high levels of markers of inflammation in the present study suggest the prevention and systematic and vigorous management of infections assumes a central and critical position in improvement of health among Aboriginal Australians living in remote communities. Pharmacological agents, especially statins and ACE-inhibitors, which are cardiovascular and renal protective, also have antiinflammatory effects that have been suggested to explain part of their action [50] . These agents, however, are likely to remain restricted to roles in secondary and tertiary prevention. The greatest challenge is to reduce the community-wide burden and transmission of infections through intersectoral and public health initiatives to improve housing, hygiene, education and nutrition.
